Business Strategy for Pharmaceuticals/Drugs in India

The market for pharmaceuticals/drugs in India is approximately $22 billion.

Western pharmaceutical/drug companies are using multiple business strategies in India today. While a number of foreign manufacturers are selling or planning to sell their drugs and pharmaceuticals in India, others are sourcing/manufacturing, doing R+D, and performing clinical trials. Should a foreign drug company set up a representative office, branch office, joint venture, or subsidiary in India today?

PBM will study the various opportunities for your pharmaceutical/drug products and come up with the best strategy for you.

For more information on developing your India business strategy, please see the following PBM publications and/or contact us to discuss your specific needs.

India Pharmaceutical Regulatory Report 2011 (publication for sale)
India Medical Devices Manufacturers, Distributors, Exporters Directory 2011 (First of its kind!)
Doing Business in India (webcast for sale)
Managing Asian Cultural Diversity: Cross-Cultural Issues in Asia (webcast for sale)
Pharmaceuticals in India: A Business and Regulatory Outlook
Strategies for Success in China, Japan, and India (webcast for sale)
Indian Pharmaceutical Industry: Market, Regulatory, Import, and Investment Regime